New Tax Law Raises Orphan Drug Costs for Medicare Recipients
Medicare's drug price negotiation program is set for changes that could result in at least $5 billion in additional spending and increased out-of-pocket costs for beneficiaries.
Yearly Archives
2025
Goldman Sachs to Host Largest Small Business Owners Gathering in Washington D.C.
Goldman Sachs to host largest gathering of small business owners in Washington D.C., offering networking…
Centene Recognized in Forbes’ Inaugural Ranking of Best US Company Cultures
Centene lands on Forbes' inaugural ranking of America's Best Employers for Company Culture, highlighting its…
New APSA Officers and Council Members Elected; Terms Begin in September
Congratulations to the new APSA Officers and Council Members. They began their terms following the 2025 APSA Annual Meeting.
HR 5031 Passage Crucial for Seniors’ Drug Access
Key healthcare associations call for Congress to pass HR 5031, ensuring continued access to vital medications for…
Democrats Push Back on Trump’s Attempt to Gut Healthcare, Warn of Shutdown
Hakeem Jeffries, the Democratic Leader, speaks on MSNBC about House Democrats pushing back against Trump's efforts…
EV sales surge ahead of federal incentives expiration
Federal consumer incentives for electric and hybrid vehicles will end in 2025, earlier than previously intended.
Tuesday Tech & Fitness: Crew’s Busy Day with PC Upgrades and Exercise…
Expedition 73 Crew Embarks on Health and Technology Research
The crew members of the Expedition 73 embarked on a…
NJCU Introduces New Minor in Finance for All Majors to Boost Career Prospects
New Jersey City University introduces a new minor in finance, offering two academic tracks to enhance students'…
Demystifying U.S. Healthcare Pricing: An Insightful Discussion with Ashish Mandavia
Discover how systemic misaligned incentives, opaque insurance practices, and weak enforcement drive up patient costs and mistrust in the health care system, and learn about possible solutions.